NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.750
-0.360 (-8.76%)
At close: Jul 24, 2026, 4:00 PM EDT
3.760
+0.010 (0.27%)
After-hours: Jul 24, 2026, 7:50 PM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $157.16 million as of July 24, 2026. Its market cap has increased by 199.93% in one year.
Market Cap
157.16M
Enterprise Value
151.38M
1-Year Change
199.93%
Ranking
Category
Stock Price
$3.75
ChartMarket Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $157.16M, an increase of 138.85%. That is a compound annual growth rate of 10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 135.90M | 78.58% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 177.89M |
| AN2 Therapeutics | 177.20M |
| Corbus Pharmaceuticals Holdings | 172.68M |
| Humacyte | 172.19M |
| OnKure Therapeutics | 170.47M |
| Oramed Pharmaceuticals | 170.25M |
| Equillium | 170.08M |
| Pyxis Oncology | 169.79M |